For the quarterly period ended March 31, 2021 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from _____ to _____ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission file number 001-33957 HARVARD BIOSCIENCE, INC. (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdiction of (I.R.S. Employ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2020 or ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number 001-33957 ___________________________ HARVARD BIOSCIENCE, INC. (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdiction of (I.R.S. Employer Incorporation o ...

Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2020 Earnings Conference Call March 10, 2021 8:00 AM ET Company Participants Dave Sirois - Director, Corporate Accounting & SEC Reporting Jim Green - Chairman of the Board, President & Chief Executive Officer Mike Rossi - Chief Financial Officer Conference Call Participants Paul Knight - KeyBanc Bruce Jackson - The Benchmark Company Tim Chiang - Northland Securities Lisa Springer - Singular Research Operator Good morning, ladies and gentlemen, and welcome to the Q4 ...

NASDAQ: HBIO Q4'20 Earnings Presentation Jim Green, Chairman, President & CEO Mike Rossi, CFO March 10, 2021 Forward-Looking Statements and Non-GAAP Financial Information Forward-Looking Statements Information in this presentation or in oral statements of the management of the Company may include forward-looking statements within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995. You can identify these statements by our use of such words as "will," "g ...

NASDAQ: HBIO Q3'20 Earnings Presentation Jim Green, Chairman, President & CEO Mike Rossi, CFO November 5, 2020 Forward-Looking Statements and Non-GAAP Financial Information Forward-Looking Statements Information in this presentation or in oral statements of the management of the Company may include forward-looking statements within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995. You can identify these statements by our use of such words as "will," ...

Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2020 Earnings Conference Call November 5, 2020 8:00 AM ET Company Participants David Sirois - Director, Corporate Accounting & SEC Reporting Jim Green - Chairman of the Board, President and Chief Executive Officer Mike Rossi - Chief Financial Officer Conference Call Participants Lisa Springer - Singular Research Bruce Jackson - The Benchmark Company Operator Thank you for standing by, and welcome to the Third Quarter 2020, Harvard Bioscience Inc, Earnings Conference ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2020 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 001-33957 HARVARD BIOSCIENCE, INC. (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdiction of (I.R.S. Employer Incor ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2020 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 001-33957 HARVARD BIOSCIENCE, INC. (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdiction of (I.R.S. Employer Incorporat ...

NASDAQ: HBIO Q2'20 Earnings Presentation Jim Green, Chairman, President & CEO Mike Rossi, CFO August 5, 2020 Forward-Looking Statements and Non-GAAP Financial Information Forward-Looking Statements This information in this presentation or in oral statements of the management of the Company may include forward-looking statements within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995. You can identify these statements by our use of such words as "will ...

Harvard Bioscience, Inc. (NASDAQ:HBIO) Q2 2020 Earnings Conference Call August 5, 2020 8:00 AM ET Company Participants David Sirois – Director of Corporate Accounting and SEC Reporting Jim Green – Chairman of the Board, President and Chief Executive Officer Mike Rossi – Chief Financial Officer Conference Call Participants Bruce Jackson – The Benchmark Company Lisa Springer – Singular Research Operator Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Harvard Biosciences Incorpora ...